$59.61 -0.10 (-0.17%)
11/20/2009 4:00 PM

Cephalon, Inc. (CEPH)

CAPS Rating: 4 out of 5

An international biopharmaceutical company dedicated to the discovery, development and marketing of innovative products to treat human diseases. Currently its four core therapeutic areas are central nervous system disorders, pain, cancer and addiction.

Current Price $59.61 Mkt Cap $4.45B
Open $59.39 P/E Ratio 15.15
Prev. Close $59.71 Div. (Yield) N/A (N/A)
Daily Range $59.38 - $60.00 Volume 1,941,477
52-Wk Range $52.55 - $81.35 Avg. Daily Vol. 2,213,000

CEPH News and Commentary

Caps

How do you think CEPH will perform vs the S&P 500?

Add Stock to Watchlist

All Members

336 Outperform
15 Underperform
 

All-Star Members

112 Outperform
6 Underperform
 

Wall Street

10 Outperform
2 Underperform
 

Top CEPH Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

kkconway (90.24)
Submitted October 22, 2009

Tough year for a proven winner; drugs in pipeline give it a 'shot' for a turnaround.

0 Comments | Reply | Report this Post

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CEPH VS S&P 500 (SPY)

Fools bullish on CEPH are also bullish on:

Fools bearish on CEPH are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about CEPH.

Recs

0
Member Avatar scoobamang (91.10) Submitted: 11/7/2009 10:02:26 PM : Outperform Start Price: $58.18 CEPH Score: +1.09

Good fundamentals for a big company in the pharmaceutical industry. Increasing revenue and profit and near 52 week low.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar MagicDiligence (83.27) Submitted: 11/5/2009 7:11:07 AM : Outperform Start Price: $57.27 CEPH Score: +0.52

Cephalon has three drugs with good growth potential. If sales develop according to the company's plan, the current price will prove to be a bargain.

http://www.magicdiligence.com/articles/cephalon-CEPH-review-2009-11-05

Report this Post 0 Comments | Reply | Permalink

Recs

1
Member Avatar kkconway (90.24) Submitted: 10/22/2009 3:36:22 PM : Outperform Start Price: $54.83 CEPH Score: +8.64

Tough year for a proven winner; drugs in pipeline give it a 'shot' for a turnaround.

Report this Post 0 Comments | Reply | Permalink
View All 36 Pitches »

Leaderboard

Find the members with the highest scoring picks in CEPH.

Score Leader

LawfordCap

LawfordCap (99.93) Score: +57.26

The Score Leader is the member with the highest score across all their picks in CEPH.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
GC39 86.17 11/10/2008 11/6/2009 Underperform 5Y $72.00 -17.21% +17.98% +35.18
FreethinkerKW 57.80 9/18/2006 Outperform 5Y $55.50 +7.41% -11.86% +19.26 1 Comment
jcpalmer 87.26 9/15/2006 9/29/2009 Outperform 3Y $55.89 +6.66% -12.44% +19.09 1 Comment
reagansgenius < 20 9/22/2006 Outperform 1Y $56.88 +4.80% -11.82% +16.62 1 Comment
JOHJAS 27.63 2/14/2008 Outperform 1Y $59.84 -0.38% -16.72% +16.34
sajh37 59.11 9/1/2006 10/31/2009 Outperform 1Y $57.08 +4.43% -11.05% +15.48
jonahpsmith 50.67 2/26/2008 Outperform NS $60.75 -1.88% -16.99% +15.11
kalanikai1 26.62 4/25/2008 Outperform NS $62.00 -3.85% -18.62% +14.77
XMFMYCROFT 96.63 9/10/2008 Underperform NS $77.05 -22.63% -8.84% +13.79
martiantrader 83.82 7/10/2009 Underperform 1Y $53.50 +11.42% +25.16% +13.74
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackRWBaird 81.68 3/6/2009 Outperform NS $62.79 -12.17% +51.51% -63.68 10/7/2009 @ $55.15
TrackPiperJaff 78.45 12/16/2008 Outperform NS $75.60 -21.15% +27.14% -48.29
TrackStanfordRes 78.48 9/25/2008 Outperform NS $76.69 -22.27% -6.05% -16.22
TrackSoleil 84.11 1/24/2008 Outperform NS $69.43 -14.14% -15.20% +1.05
TrackFBRCapitalM 73.72 12/4/2007 Outperform NS $76.01 -6.92% -14.56% +7.64 7/10/2008 @ $70.75
TrackLehmanBros 66.51 11/14/2007 Outperform NS $77.56 -23.14% -22.89% -0.25
TrackBroadpoint.AmTech 71.55 11/6/2007 Outperform NS $74.19 -19.65% -24.03% +4.38
TrackEdwardOwens 98.46 9/30/2007 Outperform NS $73.06 -18.41% -24.86% +6.45 4 Comments
TrackJefferies 31.78 4/2/2007 Outperform NS $74.12 -19.58% -18.62% -0.96
TrackUBS 88.39 3/29/2007 Outperform NS $71.17 -16.24% -18.71% +2.46
TrackJPMorgan 73.67 1/16/2007 Outperform NS $71.47 -16.59% -18.82% +2.22
TrackBroadpoint.AmTech 71.55 11/10/2006 Outperform NS $74.14 +7.74% +11.75% -4.01 7/23/2007 @ $79.88
TrackJMP < 20 9/28/2006 Outperform NS $62.24 -4.23% -13.22% +9.00
TrackMatrix 87.46 8/25/2006 Underperform NS $57.95 +2.86% -9.97% -12.83
TrackMerriman < 20 8/10/2006 Underperform NS $56.35 +39.49% +16.11% -23.37 11/9/2007 @ $78.60
TrackJimCramer 36.31 8/9/2006 Underperform 3W $63.95 -6.79% -8.61% -1.83
TrackJimCramer 36.31 3/13/2006 Outperform 3W $82.07 -22.08% -1.42% -20.66 8/9/2006 @ $63.95

Featured Broker Partners